Request Deal Involvement

PAI Partners to acquire SGD Pharma from China Jianyin Investment for c.$1bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Bredin Prat

legal advisors

Bredin Prat

PricewaterhouseCoopers

financial advisors

PricewaterhouseCoopers

Roland Berger

commercial advisors

Roland Berger

Bank of America

financial advisors

Bank of America

ERM Group

environmental advisors

ERM Group

KPMG

environmental advisors

KPMG

Greenbrook

pr advisors

Greenbrook

Bain & Co

commercial advisors

Bain & Co

Eight Advisory

financial advisors

Eight Advisory

Citigroup

financial advisors

Citigroup

Rothschild & Co

financial advisors

Rothschild & Co

Willkie Farr & Gallagher

legal advisors

Willkie Farr & Gallagher

DGM Conseil

pr advisors

DGM Conseil

or

Principals

CHINA JIANYIN INVESTMENT LTD

vendor

CHINA JIANYIN INVESTMENT LTD

PAI PARTNERS

bidder

PAI PARTNERS

SGD SA

target

SGD SA

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - PAI Partners to acquire SGD Pharma from China Jianyin Investment for c.$1bn.